<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">06907</article-id><article-id pub-id-type="doi">10.7554/eLife.06907</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-28375"><name><surname>Unni</surname><given-names>Arun M</given-names></name><aff><institution content-type="dept">Cancer Biology Section, Cancer Genetics Branch</institution>, <institution>National Human Genome Research Institute</institution>, <addr-line><named-content content-type="city">Bethesda</named-content></addr-line>, <country>United States</country><email>arun.unni@nih.gov</email></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-29158"><name><surname>Lockwood</surname><given-names>William W</given-names></name><aff><institution content-type="dept">Cancer Biology Section, Cancer Genetics Branch</institution>, <institution>National Human Genome Research Institute</institution>, <addr-line><named-content content-type="city">Bethesda</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-29154"><name><surname>Zejnullahu</surname><given-names>Kreshnik</given-names></name><aff><institution content-type="dept">Cancer Biology Section, Cancer Genetics Branch</institution>, <institution>National Human Genome Research Institute</institution>, <addr-line><named-content content-type="city">Bethesda</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-29155"><name><surname>Lee-Lin</surname><given-names>Shih-Queen</given-names></name><aff><institution content-type="dept">Cancer Biology Section, Cancer Genetics Branch</institution>, <institution>National Human Genome Research Institute</institution>, <addr-line><named-content content-type="city">Bethesda</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-34804"><name><surname>Varmus</surname><given-names>Harold</given-names></name><aff><institution content-type="dept">Meyer Cancer Center</institution>, <institution>Weill Cornell Medical College</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1069"><name><surname>Dang</surname><given-names>Chi Van</given-names></name><role>Reviewing editor</role><aff><institution>University of Pennsylvania</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>05</day><month>06</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e06907</elocation-id><supplementary-material><ext-link xlink:href="elife-06907-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>08</day><month>02</month><year>2015</year></date><date date-type="accepted"><day>04</day><month>06</month><year>2015</year></date></history><permissions><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0</ext-link> public domain dedication.</license-p></license></permissions><abstract><p>Human lung adenocarcinomas contain mutations in <italic>EGFR</italic> in ~15% of cases and in <italic>KRAS</italic> in ~30%, yet no individual adenocarcinoma appears to carry activating mutations in both genes, a finding we have confirmed by re-analysis of data from over 600 lung adenocarcinomas. Here we provide evidence that co-occurrence of mutations in these two genes is deleterious. In transgenic mice programmed to express both mutant oncogenes in the lung epithelium, the resulting tumors express only one oncogene. We also show that forced expression of a second oncogene in human cancer cell lines with an endogenous mutated oncogene is deleterious. The most prominent features accompanying loss of cell viability were vacuolization, other changes in cell morphology, and increased macropinocytosis. Activation of ERK, p38 and JNK in the dying cells suggests that an overly active MAPK signaling pathway may mediate the phenotype. Together, our findings indicate that mutual exclusivity of oncogenic mutations may reveal unexpected vulnerabilities and therapeutic possibilities.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (G-10-6).</p></fn></fn-group></back></article>